Donald J. Trump
http://www.trumponline.com/Donald Trump is a real estate developer, American business executive, and entrepreneur. He is the CEO of Trump Organization, a real estate development company based in New York.
Trump graduated from the Wharton School of Business at the University of Pennsylvania in 1968 with a BS in economics and a concentration in finance. He then joined his father's company, the Trump Organization, where he developed and revitalized properties in Manhattan.
Trump found additional success as a TV star on the hit show The Apprentice, where he coined the term 'You're Fired!'.
In 2016, Trump ran for President of the U.S. as a Republican. After topping a large field of 16 other Republicans he was selected as the nominees. He then faced Democrat Hillary Clinton and beat her in a contentious race to become President of the U.S. Trump's platform of 'Make America Great Again' and 'Drain the Swamp' resonated with white, working class citizens.
-
European stocks rise for fourth day on healthcare bounce
-
More drugmakers hike U.S. prices as new year begins
-
Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
-
Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
-
European stocks end flat as defensive gains offset auto slide
-
Pfizer to spinoff, merge off-patent drugs unit with Mylan
-
Exclusive: Big Pharma returning to U.S. price hikes in January after pause
-
Relief rally boosts Wall Street on U.S.-China trade truce
-
U.S.-China trade truce triggers European share surge
-
Health stocks up on U.S. vote; insurers hit records
-
Novartis hands investors Alcon spin-off, $5 billion share buyback
-
International fund managers turn to financials, tech as trade worries rise
-
European shares suffer as trade jitters, weak data weigh
-
Novartis CEO sees no need for big takeover
-
Trump chooses Gottlieb to run FDA; Pharma breathes sigh of relief
-
New GlaxoSmithKline CEO prepares for R&D choices, potential deals
-
Sanofi, GSK expect further price pressure, more M&A under Trump
-
AstraZeneca sees big healthcare changes under Trump
-
Complete Donald Trump Stock Impact Guide